UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $11,872,000 | +175.3% | 322,344 | +236.8% | 0.67% | +150.2% |
Q2 2020 | $4,312,000 | -69.9% | 95,700 | -52.1% | 0.27% | -72.4% |
Q4 2019 | $14,324,000 | +188.6% | 199,884 | +58.5% | 0.97% | +127.6% |
Q3 2019 | $4,963,000 | +100.8% | 126,100 | +298.7% | 0.43% | +97.2% |
Q2 2019 | $2,471,000 | -24.2% | 31,625 | -42.1% | 0.22% | -11.1% |
Q1 2019 | $3,258,000 | – | 54,625 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |